JEANNE BENSON: Open Payments
NPI 1982648382 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,278 in 60 payments from 16 companies in 2025. Trend: 2023 $3,983 · 2024 $1,729 · 2025 $1,278
Food & beverage: $1,278
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 11 | $296 |
| ABBVIE INC. | 24 | $226 |
| PFIZER INC. | 5 | $163 |
| ARGENX US, INC. | 1 | $104 |
| Amgen Inc. | 2 | $85 |
| Amneal Pharmaceuticals LLC | 2 | $77 |
| Eisai Inc. | 4 | $72 |
| EMD Serono, Inc. | 1 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Genentech USA, Inc. | 2 | $41 |
Products named: QULIPTA, VYVGART, XCOPRI, ZAVZPRET, NURTEC ODT, CREXONT, Leqembi, Mavenclad.
Industry payments across MS — which companies pay providers there.
